WHO (2024, September 4). Global hepatitis report 2024: Action for access in low-and middle-income countries. https://www.who.int/publications/i/item/9789240091672

Younossi, Z., Park, H., Henry, L., Adeyemi, A., & Stepanova, M. (2016). Extrahepatic manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology, 150(7), 1599–1608. https://doi.org/10.1053/j.gastro.2016.02.039

Article  PubMed  Google Scholar 

Wilson, I. B. (1995). Linking clinical variables with Health-Related Quality of Life: A conceptual model of patient outcomes. Journal of the American Medical Association, 273(1), 59. https://doi.org/10.1001/jama.1995.03520250075037

Article  CAS  PubMed  Google Scholar 

Schulte, B., Schmidt, C. S., Manthey, J., Strada, L., Christensen, S., Cimander, K., Görne, H., Khaykin, P., Scherbaum, N., Walcher, S., Mauss, S., Schäfer, I., Verthein, U., Rehm, J., & Reimer, J. (2020). Clinical and patient-reported outcomes of direct-acting antivirals for the Treatment of Chronic Hepatitis C among patients on opioid agonist treatment: A real-world prospective cohort study. Open Forum Infectious Diseases, 7(8), ofaa317. https://doi.org/10.1093/ofid/ofaa317

Article  PubMed  PubMed Central  Google Scholar 

Jang, E. S., Kim, Y. S., Kim, K. A., Lee, Y. J., Chung, W. J., Kim, I. H., Lee, B. S., & Jeong, S. H. (2018). Factors Associated with Health-related quality of life in Korean patients with chronic Hepatitis C infection using the SF-36 and EQ-5D. Gut and Liver, 12(4), 440–448. https://doi.org/10.5009/gnl17322

Article  PubMed  PubMed Central  Google Scholar 

Juanbeltz, R., Castilla, J., Martínez-Baz, I., O’Leary, A., Sarobe, M., & San Miguel, R. (2019). Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: A comparison with the general population. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation, 28(6), 1477–1484. https://doi.org/10.1007/s11136-019-02111-1

Article  PubMed  Google Scholar 

Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N.,Abergel, A., Mangia, A., Lai, C.-L., Chan, H. L. Y., Mazzotta, F., Moreno, C., Yoshida,E., Shafran, S. D., Towner, W. J., Tran, T. T., McNally, J., Osinusi, A., Svarovskaia,E.,… Zeuzem, S. (2015). Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. New England Journal of Medicine, 373(27), 2599–2607. https://doi.org/10.1056/NEJMoa1512610.

Evon, D. M., Sarkar, S., Amador, J., Lok, A. S., Sterling, R. K., Stewart, P. W., Reeve, B. B., Serper, M., Reau, N., Reddy, R., Di Bisceglie, K., Nelson, A. M., Golin, D. R., Lim, C. E., J. K., & Fried, M. W. (2019). Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study. Journal of Hepatology, 71(3), 486–497. https://doi.org/10.1016/j.jhep.2019.04.016

Article  PubMed  PubMed Central  Google Scholar 

Goñi Esarte, S., Juanbeltz, R., Martínez-Baz, I., Castilla, J., San Miguel, R., Herrero, J. I, & Zozaya, J. M (2019). Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents. Revista Española De Enfermedades Digestivas, 111. https://doi.org/10.17235/reed.2019.6063/2018

Kierepa, A., Witkowska, A., Kaczmarek, M., Książek, K., Mikuła-Pietrasik, J., Żeromski, J., Kowala-Piaskowska, A., & Mozer-Lisewska, I. (2020). Impact of chronic HCV treatment on quality of life of patients with metabolic disorders in context of immunological disturbances. Scientific Reports, 10(1), 10388. https://doi.org/10.1038/s41598-020-67296-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

DOICA, I. P., TURCU-STIOLICA, A., FLORESCU, U. N. G. U. R. E. A. N. U. B. S., D. N., ROGOVEANU, I., & GHEONEA, D. I. (2023). Association between Direct-Acting agents Adherence and Health-related quality of life of patients with Hepatitis C. Current Health Sciences Journal, 3, 312–318. https://doi.org/10.12865/CHSJ.49.03.02

Article  Google Scholar 

Benade, M., Rosen, S., Antoniak, S., Chasela, C., Stopolianska, Y., Barnard, T., Gandhi, M. M., Ivanchuk, I., Tretiakov, V., Dible, J., Minior, T., Chew, K. W., Van Der Horst, C., Tsenilova, Z., & Sanne, I. (2022). Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adults in Ukraine. BMC Infectious Diseases, 22(1), 650. https://doi.org/10.1186/s12879-022-07615-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, R., Shang, J., Chen, H., Li, J., Xie, Q., Feng, J., Wei, L., & Rao, H. (2024). Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: A prospective national study in China. BMC Infectious Diseases, 24(1), 72. https://doi.org/10.1186/s12879-023-08940-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carrieri, P., Bourlière, M., Di Beo, V., Lusivika-Nzinga, C., Ramier, C., Antwerpes, S., Protopopescu, C., Lacombe, J. M., Pol, S., Fontaine, H., Mourad, A., Carrat, F., Duracinsky, M., Marcellin, F., & ANRS/AFEF HEPATHER Study Group. (2023). Impaired health-related quality of life in the HCV cure era: Who is concerned? (ANRS CO22 HEPATHER French cohort). Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation, 32(12), 3427–3438. https://doi.org/10.1007/s11136-023-03496-w

Article  PubMed  Google Scholar 

McDonald, S. A., Myring, G., Palmateer, N. E., McAuley, A., Beer, L., Dillon, J. F., Hollingworth, W., Gunson, R., Hickman, M., & Hutchinson, S. J. (2023). Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable. Addiction, 118(7), 1340–1350. https://doi.org/10.1111/add.16169

Article  PubMed  Google Scholar 

Solomon, S. S., Wagner-Cardoso, S., Smeaton, L., Sowah, L. A., Wimbish, C., Robbins, G., Brates, I., Scello, C., Son, A., Avihingsanon, A., Linas, B., Anthony, D., Nunes, E. P., Kliemann, D. A., Supparatpinyo, K., Kityo, C., Tebas, P., Bennet, J. A., Santana-Bagur, J., & Sulkowski, M. (2022). A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): A phase 4, open-label, single-arm trial. The Lancet Gastroenterology & Hepatology, 7(4), 307–317. https://doi.org/10.1016/S2468-1253(21)00397-6

Article  CAS  Google Scholar 

WHO (2010). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). https://www.who.int/publications/i/item/978924159938-2

EuroQol Research Foundation (2023). EQ-5D. https://euroqol.org/

Chong, C. A. K. Y., Gulamhussein, A., Heathcote, E. J., Lilly, L., Sherman, M., Naglie, G., & Krahn, M. (2003). Health-State Utilities and Quality of Life in Hepatitis C patients. The American Journal of Gastroenterology, 98(3), 630–638. https://doi.org/10.1111/j.1572-0241.2003.07332.x

Article  PubMed  Google Scholar 

Vera-Llonch, M., Martin, M., Aggarwal, J., Donepudi, M., Bayliss, M., Goss, T., & Younossi, Z. (2013). Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study. Alimentary Pharmacology & Therapeutics, 38(2), 124–133. https://doi.org/10.1111/apt.12354

Article  CAS  Google Scholar 

Ng, M., Hayashi, K., Voon, P., Shulha, H. P., DeBeck, K., Milloy, M. J., & Ti, L. (2019). Characterising the association between positive hepatitis C virus antibody and pain among people who inject drugs. Drug and Alcohol Review, 38(6), 639–643. https://doi.org/10.1111/dar.12969

Article  PubMed  PubMed Central  Google Scholar 

Gormley, M. A., Akiyama, M. J., Rennert, L., Howard, K. A., Norton, B. L., Pericot-Valverde, I., Muench, S., Heo, M., & Litwin, A. H. (2022). Changes in Health-related quality of life for Hepatitis C virus–infected people who inject drugs while on opioid agonist treatment following sustained Virologic response. Clinical Infectious Diseases, 74(9), 1586–1593. https://doi.org/10.1093/cid/ciab669

Article  CAS  PubMed  Google Scholar 

Viegas Andrade, M., Noronha, K., Kind, P., Maia, A. C., de Menezes, M., De Barros Reis, R., Souza, C. N., Martins, M., Gomes, D., Nichele, L., Calazans, D., Mascarenhas, J., Carvalho, T., L., & Lins, C. (2013). Societal preferences for EQ-5D Health states from a Brazilian Population Survey. Value in Health Regional Issues, 2(3), 405–412. https://doi.org/10.1016/j.vhri.2013.01.009

Article  PubMed  Google Scholar 

Tongsiri, S., & Cairns, J. (2011). Estimating Population-based values for EQ-5D Health states in Thailand. Value in Health, 14(8), 1142–1145. https://doi.org/10.1016/j.jval.2011.06.005

Article  PubMed  Google Scholar 

Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US Valuation of the EQ-5D Health states: Development and Testing of the D1 valuation model. Medical Care, 43(3), 203–220.

Article  PubMed  Google Scholar 

Jelsma, J., Hansen, K., de Weerdt, W., de Cock, P., & Kind, P. (2003). How do zimbabweans value health states? Population Health Metrics, 1(1), 11. https://doi.org/10.1186/1478-7954-1-11

Article  PubMed  PubMed Central  Google Scholar 

Veracruz, N., Gish, R. G., Cheung, R., Chitnis, A. S., & Wong, R. J. (2022). Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years. Liver International, 42(10), 2145–2153. https://doi.org/10.1111/liv.15347

Article  CAS  PubMed  Google Scholar 

Heath, K., & Hill, A. (2024). WHO Hepatitis C elimination targets: The global equity challenge. The Lancet Gastroenterology & Hepatology, 9(4), 286–288. https://doi.org/10.1016/S2468-1253(23)00408-9

Article  CAS  Google Scholar 

Marshall, P. A. (1990). Cultural influences on perceived quality of life. Seminars in Oncology Nursing, 6(4), 278–284. https://doi.org/10.1016/0749-2081(90)90030-9

Article  CAS  PubMed  Google Scholar 

WHO. (2023). Mental health of older adults: text=Some%20older%20adults%20are%20at,to%20quality%20support%20and%20services. https://www.who.int/news-room/fact-sheets/detail/mental-health-of-older-adults#:~:text=Some%20older%20adults%20are%20at,to%20quality%20support%20and%20services

NIH (2024). Substance Use and Co-Occurring Mental Disorders. https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health

Bratu, M. L., Sandesc, D., Anghel, T., Tudor, R., Shaaban, L., Ali, A., Toma, A. O., Bratosin, F., Turcu, I., Gantsa, A., Fericean, R. M., Bondrescu, M., & Barata, P. I. (2023). Evaluating the as